Rebecca A. Taub's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 491 Common Stock done at an average price of $431.9 . Disclosure was reported to the exchange on March 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 431.94 per share. | 06 Mar 2026 | 491 | 452,213 (2%) | 0% | 431.9 | 212,083 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 492.42 per share. | 26 Jan 2026 | 647 | 452,704 (2%) | 0% | 492.4 | 318,596 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 490.77 per share. | 20 Jan 2026 | 2,238 | 453,351 (2%) | 0% | 490.8 | 1,098,343 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 09 Jan 2026 | 18,410 | 473,999 (3%) | 0% | 15.8 | 290,878 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 18,410 | 240 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 517.84 per share. | 09 Jan 2026 | 2,044 | 466,999 (3%) | 0% | 517.8 | 1,058,468 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 515.82 per share. | 09 Jan 2026 | 1,578 | 469,564 (3%) | 0% | 515.8 | 813,968 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 525.12 per share. | 09 Jan 2026 | 1,489 | 460,906 (2%) | 0% | 525.1 | 781,903 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 524.06 per share. | 09 Jan 2026 | 1,335 | 462,395 (2%) | 0% | 524.1 | 699,623 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 526.95 per share. | 09 Jan 2026 | 1,135 | 458,858 (2%) | 0% | 527.0 | 598,091 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 518.67 per share. | 09 Jan 2026 | 970 | 466,029 (3%) | 0% | 518.7 | 503,106 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 512.02 per share. | 09 Jan 2026 | 960 | 473,039 (3%) | 0% | 512.0 | 491,537 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 513.12 per share. | 09 Jan 2026 | 960 | 472,079 (3%) | 0% | 513.1 | 492,595 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 514.63 per share. | 09 Jan 2026 | 937 | 471,142 (3%) | 0% | 514.6 | 482,207 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 526.05 per share. | 09 Jan 2026 | 913 | 459,993 (2%) | 0% | 526.0 | 480,281 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 522.98 per share. | 09 Jan 2026 | 732 | 463,730 (3%) | 0% | 523.0 | 382,823 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 521.95 per share. | 09 Jan 2026 | 588 | 464,462 (3%) | 0% | 522.0 | 306,909 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 529.28 per share. | 09 Jan 2026 | 554 | 457,839 (2%) | 0% | 529.3 | 293,222 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 519.89 per share. | 09 Jan 2026 | 539 | 465,490 (3%) | 0% | 519.9 | 280,220 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 516.81 per share. | 09 Jan 2026 | 521 | 469,043 (3%) | 0% | 516.8 | 269,257 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 528.16 per share. | 09 Jan 2026 | 465 | 458,393 (2%) | 0% | 528.2 | 245,593 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 521.11 per share. | 09 Jan 2026 | 440 | 465,050 (3%) | 0% | 521.1 | 229,289 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 539.26 per share. | 09 Jan 2026 | 400 | 456,029 (2%) | 0% | 539.3 | 215,706 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 542.72 per share. | 09 Jan 2026 | 400 | 455,589 (2%) | 0% | 542.7 | 217,088 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 536.88 per share. | 09 Jan 2026 | 385 | 456,469 (2%) | 0% | 536.9 | 206,700 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 535.80 per share. | 09 Jan 2026 | 299 | 456,854 (2%) | 0% | 535.8 | 160,205 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 534.17 per share. | 09 Jan 2026 | 271 | 457,242 (2%) | 0% | 534.2 | 144,761 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 530.45 per share. | 09 Jan 2026 | 256 | 457,583 (2%) | 0% | 530.5 | 135,796 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 240 | 0 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 09 Jan 2026 | 240 | 455,829 (2%) | 0% | 15.8 | 3,792 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 551.24 per share. | 09 Jan 2026 | 200 | 455,589 (2%) | 0% | 551.2 | 110,248 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 534.93 per share. | 09 Jan 2026 | 89 | 457,153 (2%) | 0% | 534.9 | 47,609 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 532.50 per share. | 09 Jan 2026 | 40 | 457,513 (2%) | 0% | 532.5 | 21,300 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 537.85 per share. | 09 Jan 2026 | 40 | 456,429 (2%) | 0% | 537.9 | 21,514 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 540.25 per share. | 09 Jan 2026 | 40 | 455,989 (2%) | 0% | 540.3 | 21,610 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 545.80 per share. | 09 Jan 2026 | 40 | 455,789 (2%) | 0% | 545.8 | 21,832 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 531.07 per share. | 09 Jan 2026 | 30 | 457,553 (2%) | 0% | 531.1 | 15,932 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 10 Dec 2025 | 18,650 | 479,694 (3%) | 0% | 15.8 | 294,670 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 18,650 | 18,650 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Dec 2025 | 5,455 | 455,589 (2%) | 0% | 0 | Common Stock | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 550.99 per share. | 10 Dec 2025 | 4,723 | 473,625 (3%) | 0% | 551.0 | 2,602,307 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 551.85 per share. | 10 Dec 2025 | 4,410 | 469,215 (3%) | 0% | 551.8 | 2,433,641 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 552.81 per share. | 10 Dec 2025 | 3,857 | 465,358 (3%) | 0% | 552.8 | 2,132,197 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 553.88 per share. | 10 Dec 2025 | 3,087 | 462,271 (2%) | 0% | 553.9 | 1,709,826 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 554.84 per share. | 10 Dec 2025 | 1,027 | 461,244 (2%) | 0% | 554.8 | 569,822 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 547.76 per share. | 10 Dec 2025 | 491 | 479,203 (3%) | 0% | 547.8 | 268,949 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 550.07 per share. | 10 Dec 2025 | 486 | 478,348 (3%) | 0% | 550.1 | 267,335 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 548.56 per share. | 10 Dec 2025 | 369 | 478,834 (3%) | 0% | 548.6 | 202,418 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 555.39 per share. | 10 Dec 2025 | 200 | 461,044 (2%) | 0% | 555.4 | 111,078 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 43,263 | 0 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 11 Aug 2025 | 43,263 | 504,307 (3%) | 0% | 9.4 | 408,835 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 357.85 per share. | 11 Aug 2025 | 6,715 | 468,285 (3%) | 0% | 357.9 | 2,402,982 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 358.81 per share. | 11 Aug 2025 | 6,541 | 461,744 (2%) | 0% | 358.8 | 2,346,983 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 354.97 per share. | 11 Aug 2025 | 6,479 | 485,616 (3%) | 0% | 355.0 | 2,299,873 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 355.95 per share. | 11 Aug 2025 | 5,752 | 479,864 (3%) | 0% | 356.0 | 2,047,436 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 356.88 per share. | 11 Aug 2025 | 4,864 | 475,000 (3%) | 0% | 356.9 | 1,735,861 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 354.04 per share. | 11 Aug 2025 | 4,587 | 492,095 (3%) | 0% | 354.0 | 1,623,997 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.87 per share. | 11 Aug 2025 | 3,580 | 500,727 (3%) | 0% | 350.9 | 1,256,127 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 3,200 | 43,263 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 11 Aug 2025 | 3,200 | 464,244 (3%) | 0% | 9.5 | 30,240 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.18 per share. | 11 Aug 2025 | 2,980 | 461,264 (2%) | 0% | 350.2 | 1,043,528 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 351.60 per share. | 11 Aug 2025 | 2,870 | 497,857 (3%) | 0% | 351.6 | 1,009,091 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 352.45 per share. | 11 Aug 2025 | 1,175 | 496,682 (3%) | 0% | 352.5 | 414,130 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 359.71 per share. | 11 Aug 2025 | 700 | 461,044 (2%) | 0% | 359.7 | 251,798 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 351.02 per share. | 11 Aug 2025 | 220 | 461,044 (2%) | 0% | 351.0 | 77,225 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 18 Jul 2025 | 1,000 | 461,044 (2%) | 0% | 350.0 | 350,005 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 18 Jul 2025 | 1,000 | 462,044 (2%) | 0% | 9.5 | 9,450 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2025 | 1,000 | 46,463 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 26,444 | 50,120 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 16 Jul 2025 | 26,444 | 487,488 (3%) | 0% | 9.5 | 249,896 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 355.61 per share. | 16 Jul 2025 | 6,441 | 462,424 (2%) | 0% | 355.6 | 2,290,499 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.19 per share. | 16 Jul 2025 | 6,000 | 481,488 (3%) | 0% | 350.2 | 2,101,142 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 354.61 per share. | 16 Jul 2025 | 5,800 | 468,865 (3%) | 0% | 354.6 | 2,056,738 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 2,657 | 47,463 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 16 Jul 2025 | 2,657 | 463,701 (3%) | 0% | 9.5 | 25,109 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 353.82 per share. | 16 Jul 2025 | 2,569 | 474,665 (3%) | 0% | 353.8 | 908,963 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 352.64 per share. | 16 Jul 2025 | 2,357 | 477,234 (3%) | 0% | 352.6 | 831,170 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.09 per share. | 16 Jul 2025 | 2,057 | 461,644 (2%) | 0% | 350.1 | 720,137 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 351.37 per share. | 16 Jul 2025 | 1,897 | 479,591 (3%) | 0% | 351.4 | 666,546 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 356.52 per share. | 16 Jul 2025 | 1,380 | 461,044 (2%) | 0% | 356.5 | 492,004 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 351.50 per share. | 16 Jul 2025 | 600 | 461,044 (2%) | 0% | 351.5 | 210,898 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 7,381 | 7,381 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 4,382 | 461,044 (2%) | 0% | 0 | Common Stock | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 335.24 per share. | 24 Jan 2025 | 648 | 456,662 (2%) | 0% | 335.2 | 217,236 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 273.41 per share. | 17 Jan 2025 | 1,689 | 457,310 (2%) | 0% | 273.4 | 461,789 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 08 Apr 2024 | 2,676 | 461,675 (2%) | 0% | 9.4 | 25,288 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 2,676 | 76,564 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 244.79 per share. | 08 Apr 2024 | 945 | 460,506 (2%) | 0% | 244.8 | 231,325 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 246.98 per share. | 08 Apr 2024 | 600 | 459,606 (2%) | 0% | 247.0 | 148,186 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 247.76 per share. | 08 Apr 2024 | 407 | 459,199 (2%) | 0% | 247.8 | 100,838 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 245.69 per share. | 08 Apr 2024 | 300 | 460,206 (2%) | 0% | 245.7 | 73,706 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 243.25 per share. | 08 Apr 2024 | 224 | 461,451 (2%) | 0% | 243.2 | 54,487 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 248.58 per share. | 08 Apr 2024 | 200 | 458,999 (2%) | 0% | 248.6 | 49,716 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 27,845 | 125,283 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 03 Apr 2024 | 27,845 | 486,844 (3%) | 0% | 9.4 | 263,135 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 27,506 | 79,240 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 03 Apr 2024 | 27,506 | 486,505 (3%) | 0% | 9.5 | 259,932 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 245.34 per share. | 03 Apr 2024 | 18,917 | 461,088 (2%) | 0% | 245.3 | 4,641,014 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 18,537 | 106,746 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 03 Apr 2024 | 18,537 | 477,536 (3%) | 0% | 9.5 | 175,175 | Common Stock |
| Madrigal Pharma Inc | Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 243.33 per share. | 03 Apr 2024 | 8,989 | 466,356 (3%) | 0% | 243.3 | 2,187,288 | Common Stock |